Literature DB >> 20513550

Yellow fever: a reemerging threat.

Christina L Gardner1, Kate D Ryman.   

Abstract

Yellow fever (YF) is a viral disease, endemic to tropical regions of Africa and the Americas, which principally affects humans and nonhuman primates and is transmitted via the bite of infected mosquitoes. Yellow fever virus (YFV) can cause devastating epidemics of potentially fatal, hemorrhagic disease. Despite mass vaccination campaigns to prevent and control these outbreaks, the risk of major YF epidemics, especially in densely populated, poor urban settings, both in Africa and South America, has greatly increased. Consequently, YF is considered an emerging, or reemerging disease of considerable importance. This article comprehensively reviews the history, microbiology, epidemiology, clinical presentation, diagnosis, and treatment of YFV, as well as the vaccines produced to combat YF. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20513550      PMCID: PMC4349381          DOI: 10.1016/j.cll.2010.01.001

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  118 in total

1.  Markers for trans-Golgi membranes and the intermediate compartment localize to induced membranes with distinct replication functions in flavivirus-infected cells.

Authors:  J M Mackenzie; M K Jones; E G Westaway
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Risk of fatal adverse events associated with 17DD yellow fever vaccine.

Authors:  C J Struchiner; P M Luz; I Dourado; H K Sato; S G Aguiar; J G L Ribeiro; R C R Soares; C T Codeço
Journal:  Epidemiol Infect       Date:  2004-10       Impact factor: 2.451

3.  Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions.

Authors:  F Guirakhoo; F X Heinz; C W Mandl; H Holzmann; C Kunz
Journal:  J Gen Virol       Date:  1991-06       Impact factor: 3.891

4.  The Pathology of the Liver in Yellow Fiver.

Authors:  O Klotz; T H Belt
Journal:  Am J Pathol       Date:  1930-11       Impact factor: 4.307

5.  The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure.

Authors:  Moheshwarnath Issur; Brian J Geiss; Isabelle Bougie; Frédéric Picard-Jean; Simon Despins; Joannie Mayette; Sarah E Hobdey; Martin Bisaillon
Journal:  RNA       Date:  2009-10-22       Impact factor: 4.942

Review 6.  New developments in flavivirus vaccines with special attention to yellow fever.

Authors:  Konstantin V Pugachev; Farshad Guirakhoo; Thomas P Monath
Journal:  Curr Opin Infect Dis       Date:  2005-10       Impact factor: 4.915

7.  Hepatitis and death following vaccination with 17D-204 yellow fever vaccine.

Authors:  R C Chan; D J Penney; D Little; I W Carter; J A Roberts; W D Rawlinson
Journal:  Lancet       Date:  2001-07-14       Impact factor: 79.321

8.  The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids.

Authors:  H Li; S Clum; S You; K E Ebner; R Padmanabhan
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

9.  Mutation in NS5 protein attenuates mouse neurovirulence of yellow fever 17D vaccine virus.

Authors:  H Xie; K D Ryman; G A Campbell; A D Barrett
Journal:  J Gen Virol       Date:  1998-08       Impact factor: 3.891

10.  THE ADAPTATION OF UNMODIFIED STRAINS OF YELLOW FEVER VIRUS TO CULTIVATION IN VITRO.

Authors:  H H Smith; M Theiler
Journal:  J Exp Med       Date:  1937-05-31       Impact factor: 14.307

View more
  71 in total

1.  Structural architecture of an RNA that competitively inhibits RNase L.

Authors:  Amanda Y Keel; Babal Kant Jha; Jeffrey S Kieft
Journal:  RNA       Date:  2011-11-23       Impact factor: 4.942

Review 2.  From dengue to Zika: the wide spread of mosquito-borne arboviruses.

Authors:  Shivani Sukhralia; Mansi Verma; Shruthi Gopirajan; P S Dhanaraj; Rup Lal; Neeti Mehla; Chhaya Ravi Kant
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-28       Impact factor: 3.267

Review 3.  The continued threat of emerging flaviviruses.

Authors:  Theodore C Pierson; Michael S Diamond
Journal:  Nat Microbiol       Date:  2020-05-04       Impact factor: 17.745

4.  A humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow fever infection in an AG129/17D-204 peripheral challenge mouse model.

Authors:  Brett A Thibodeaux; Nina C Garbino; Nathan M Liss; Joseph Piper; Jacob J Schlesinger; Carol D Blair; John T Roehrig
Journal:  Antiviral Res       Date:  2012-02-15       Impact factor: 5.970

5.  Advanced yellow fever virus genome detection in point-of-care facilities and reference laboratories.

Authors:  Cristina Domingo; Pranav Patel; Jasmin Yillah; Manfred Weidmann; Jairo A Méndez; Emmanuel Rivalyn Nakouné; Matthias Niedrig
Journal:  J Clin Microbiol       Date:  2012-10-10       Impact factor: 5.948

Review 6.  T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

Authors:  Anne Monette; Andrew J Mouland
Journal:  Int Rev Cell Mol Biol       Date:  2018-10-24       Impact factor: 6.813

Review 7.  Yellow Fever Virus: Diagnostics for a Persistent Arboviral Threat.

Authors:  Jesse J Waggoner; Alejandra Rojas; Benjamin A Pinsky
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

8.  Seroepidemiology of Dengue, Zika, and Yellow Fever Viruses among Children in the Democratic Republic of the Congo.

Authors:  Alexandra C Willcox; Matthew H Collins; Ramesh Jadi; Corinna Keeler; Jonathan B Parr; Dieudonné Mumba; Melchior Kashamuka; Antoinette Tshefu; Aravinda M de Silva; Steven R Meshnick
Journal:  Am J Trop Med Hyg       Date:  2018-07-05       Impact factor: 2.345

9.  Long-Term Protection of Rhesus Macaques from Zika Virus Reinfection.

Authors:  Gage K Moreno; Christina M Newman; Michelle R Koenig; Mariel S Mohns; Andrea M Weiler; Sierra Rybarczyk; Kim L Weisgrau; Logan J Vosler; Nicholas Pomplun; Nancy Schultz-Darken; Eva Rakasz; Dawn M Dudley; Thomas C Friedrich; David H O'Connor
Journal:  J Virol       Date:  2020-02-14       Impact factor: 5.103

10.  A basic cluster in the N terminus of yellow fever virus NS2A contributes to infectious particle production.

Authors:  Stephanie Voßmann; Janett Wieseler; Romy Kerber; Beate Mareike Kümmerer
Journal:  J Virol       Date:  2015-02-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.